Associate Director
AstraZeneca, United Kingdom
Ulrike Künzel is currently an Associate Director in the Functional Genomics team at AstraZeneca, Cambridge, United Kingdom. Her team applies CRISPR screening in primary and immune cells for target identification and target validation projects across AstraZeneca’s portfolio. Ulrike’s work as a Senior Research Scientist at AstraZeneca has focused on establishing arrayed CRISPR screening with high-content imaging endpoints for a variety of projects for oncology and kidney disease.
Before joining AstraZeneca, Ulrike worked in the Target Identification Team at Evotec in Hamburg, Germany where she developed a workflow for generating CRISPR/Cas9-engineered cell lines for target identification and target validation projects. She received a Bachelor’s and Master's degree in Biochemistry from LMU Munich, Germany and a PhD in Pathology from the University of Oxford, United Kingdom.
The application of arrayed CRISPR screening for target identification in primary cells
Wednesday, May 24, 2023
14:30 – 15:00 CET